Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.comNews Commentary – ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...

Celcuity Inc. soared on best-in-class Phase 3 breast cancer data. Click to see why I have a Buy rating on CELC due to data, regulatory filings, and potential M&A.

Detailed price information for Bridgebio Oncology Therapeutics Inc (BBOT-Q) from The Globe and Mail including charting and trades.

Additional analysis of data from a Phase 1b clinical trial that included all patients treated with gedatolisib combined with fulvestrant and palbociclib showed median progression-free survival (“PFS”) ...

Excessive protein is the current health fad. Protein is one of the three macronutrients. Fat and carbohydrates are the other two, and some experts would add fiber (a special type of carbohydrate) as a ...

Objective To explore the relationship between PIK3CA mutations and clinicopathological features and prognosis in breast cancer patients. Methods This retrospective cohort study included 283 patients ...

WASHINGTON, 2nd June, 2025 (WAM) -- A new triple therapy for aggressive, advanced breast cancer slows the progression of the disease, delays the need for further chemotherapy and helps patients live ...

1 Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, China 2 School of Pharmacy, Changchun University of Chinese Medicine, Changchun, China Depression is a psychological ...

The outlook for someone with PIK3CA-related overgrowth spectrum (PROS) depends on factors that vary from person to person. Early intervention and treatment can improve the outlook and prevent ...